Quick Answer
HARVARD BIOSCIENCE INC reported Diluted EPS of $0.12 per share (loss) for fiscal year 2019.
HARVARD BIOSCIENCE INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2019 | -$0.12 | -50.0% |
| 2018 | -$0.08 | -300.0% |
| 2017 | -$0.02 | +84.6% |
| 2016 | -$0.13 | +77.2% |
| 2015 | -$0.57 | -914.3% |
| 2014 | $0.07 | +216.7% |
| 2013 | -$0.06 | -175.0% |
| 2012 | $0.08 | -38.5% |
| 2011 | $0.13 | -80.0% |
| 2010 | $0.65 | +170.8% |
| 2009 | $0.24 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2024 | -$0.11 | -1200.0% | -450.0% |
| June 30, 2023 | -$0.02 | -133.3% | -300.0% |
| March 31, 2023 | $0.01 | +105.9% | -83.3% |
| June 30, 2022 | $0.06 | +700.0% | +135.3% |
| March 31, 2022 | -$0.17 | — | -1600.0% |
| June 30, 2021 | -$0.01 | +75.0% | +75.0% |
| June 30, 2020 | -$0.04 | -300.0% | +66.7% |
| March 31, 2020 | -$0.12 | -100.0% | -71.4% |
- HARVARD BIOSCIENCE INC showed a decrease of -50.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2019 period, HARVARD BIOSCIENCE INC’s diluted eps has declined by 150.0% (from $0.24 per share to $0.12 per share (loss)).
- The most recent figure is from HARVARD BIOSCIENCE INC’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 16, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: